RxSight Inc.
(RXST)
undefined
undefined%
At close: undefined
37.30
0.24%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -48.61M | -66.76M | -48.69M | 27.57M | 126.22M |
| Depreciation & Amortization | 4.24M | 4.02M | 3.99M | 4.01M | 3.93M |
| Stock-Based Compensation | 15.75M | 11.40M | 7.58M | 4.18M | 4.60M |
| Other Working Capital | 1.75M | 5.60M | 874.00K | -3.51M | 1.16M |
| Other Non-Cash Items | -3.90M | -101.00K | 493.00K | 85.00K | -171.40M |
| Deferred Income Tax | - | - | -5.40M | -63.21M | - |
| Change in Working Capital | -9.07M | -7.41M | -2.68M | -7.85M | -3.97M |
| Operating Cash Flow | -41.59M | -58.85M | -44.71M | -35.20M | -40.62M |
| Capital Expenditures | -4.81M | -2.39M | -1.94M | -2.54M | -4.09M |
| Acquisitions | 17.32M | -42.34M | 79.97M | 3.00K | 603.00K |
| Purchase of Investments | -272.31M | -212.66M | -159.97M | -97.87M | -132.39M |
| Sales Maturities Of Investments | 255.00M | 255.00M | 80.00M | 116.00M | 130.00M |
| Other Investing Acitivies | -17.32M | 42.34M | -79.97M | 18.13M | -1.78M |
| Investing Cash Flow | -22.13M | 39.95M | -81.91M | 15.59M | -5.87M |
| Debt Repayment | -40.15M | -121.00K | 14.97M | 24.86M | -185.00K |
| Common Stock Repurchased | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | -4.28M | -1.38M | 1.23M | 379.00K | 1.51M |
| Financial Cash Flow | 61.52M | 6.33M | 137.34M | 25.24M | 1.33M |
| Net Cash Flow | -2.19M | -12.58M | 10.72M | 5.63M | -45.15M |
| Free Cash Flow | -46.41M | -61.24M | -46.65M | -37.74M | -44.70M |